Literature DB >> 19255844

Psychological distress, somatization, and defense mechanisms associated with quality of life in inflammatory bowel disease patients.

Thomas N Hyphantis1, Barbara Tomenson, Marina Bai, Epameinondas Tsianos, Venetsanos Mavreas, Francis Creed.   

Abstract

BACKGROUND: Clinical parameters predict health-related quality of life (HRQOL) in inflammatory bowel disease (IBD), but some patients have impaired HRQOL despite being in clinical remission.
OBJECTIVE: To identify personality and psychological distress variables associated with HRQOL in IBD.
METHOD: In a cross-sectional study of 185 IBD patients, the General Health Questionnaire, the Hopkins' Symptoms Distress Checklist, the Defense Style Questionnaire and the Life Style Index were administered. The Inflammatory Bowel Disease Questionnaire was used for the assessment of HRQOL.
RESULTS: Psychological distress was associated with impaired HRQOL in a dose-response fashion. Somatization mediated the relationships of anxiety and depression with HRQOL. Few years of education, more extensive use of the reaction-formation defense mechanism and higher rates of somatization were the variables most closely and independently associated with impaired HRQOL.
CONCLUSIONS: Somatization and reaction-formation are independent correlates of disease-specific HRQOL in IBD patients, and this could be relevant to psychological interventions.

Entities:  

Mesh:

Year:  2009        PMID: 19255844     DOI: 10.1007/s10620-009-0762-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  45 in total

1.  Quality of life of Greek patients with inflammatory bowel disease. Validation of the Greek translation of the inflammatory bowel disease questionnaire.

Authors:  A G Pallis; I G Vlachonikolis; I A Mouzas
Journal:  Digestion       Date:  2001       Impact factor: 3.216

2.  Factors affecting health related quality of life of patients with inflammatory bowel disease.

Authors:  Francesc Casellas; Josefa López-Vivancos; Alfonso Casado; Juan-Ramon Malagelada
Journal:  Qual Life Res       Date:  2002-12       Impact factor: 4.147

3.  Psychological screening in rheumatoid arthritis.

Authors:  J C Parker; S P Buckelew; K L Smarr; K L Buescher; N C Beck; R G Frank; S K Anderson; S E Walker
Journal:  J Rheumatol       Date:  1990-08       Impact factor: 4.666

4.  Ulcerative colitis: factors affecting difficulties of life and psychological well being of patients in remission.

Authors:  Makoto Tanaka; Keiko Kazuma
Journal:  J Clin Nurs       Date:  2005-01       Impact factor: 3.036

5.  Health-related quality of life and psychological distress in a population-based sample of Swedish patients with inflammatory bowel disease.

Authors:  K Nordin; L Påhlman; K Larsson; M Sundberg-Hjelm; L Lööf
Journal:  Scand J Gastroenterol       Date:  2002-04       Impact factor: 2.423

6.  Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors.

Authors:  Magnus Simrén; Jenny Axelsson; Rolf Gillberg; Hasse Abrahamsson; Jan Svedlund; Einar S Björnsson
Journal:  Am J Gastroenterol       Date:  2002-02       Impact factor: 10.864

7.  Defense mechanisms in inflammatory bowel disease.

Authors:  Thomas N Hyphantis; John K Triantafillidis; Sofia Pappa; Christos Mantas; Anna Kaltsouda; Peter Cherakakis; Yannis Alamanos; Orestis N Manousos; Venetsanos G Mavreas
Journal:  J Gastroenterol       Date:  2005-01       Impact factor: 7.527

8.  The relationship of current psychiatric disorder to functional disability and distress in patients with inflammatory bowel disease.

Authors:  E A Walker; M D Gelfand; A N Gelfand; F Creed; W J Katon
Journal:  Gen Hosp Psychiatry       Date:  1996-07       Impact factor: 3.238

9.  The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome.

Authors:  Francis Creed; Lakshmi Fernandes; Elspeth Guthrie; Stephen Palmer; Joy Ratcliffe; Nicholas Read; Christine Rigby; David Thompson; Barbara Tomenson
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

10.  The validation of the GHQ-28 and the use of the MMSE in neurological in-patients.

Authors:  K W Bridges; D P Goldberg
Journal:  Br J Psychiatry       Date:  1986-05       Impact factor: 9.319

View more
  11 in total

1.  Dinitrobenzene sulphonic acid-induced colitis impairs spatial recognition memory in mice: roles of N-methyl D-aspartate receptors and nitric oxide.

Authors:  Mohammad Hadi Gharedaghi; Reza Rahimian; Ahmad Reza Dehpour; Yashar Yousefzadeh-Fard; Ahmad Mohammadi-Farani
Journal:  Psychopharmacology (Berl)       Date:  2015-05-14       Impact factor: 4.530

2.  Psychological defensive profile of sciatica patients with neuropathic pain and its relationship to quality of life.

Authors:  A Tutoglu; A Boyaci; I F Karababa; I Koca; E Kaya; A Kucuk; A Yetisgin
Journal:  Z Rheumatol       Date:  2015-09       Impact factor: 1.372

3.  Associations of sense of coherence with psychological distress and quality of life in inflammatory bowel disease.

Authors:  Thiago H Freitas; Elias Andreoulakis; Gilberto S Alves; Hesley L L Miranda; Lúcia L B C Braga; Thomas Hyphantis; André F Carvalho
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

4.  Somatization is associated with physical health-related quality of life independent of anxiety and depression in cancer, glaucoma and rheumatological disorders.

Authors:  Thomas Hyphantis; Barbara Tomenson; Vassiliki Paika; Augoustina Almyroudi; Chrisavgi Pappa; Niki Tsifetaki; Paraskevi V Voulgari; Alexandros A Drosos; Nicholas Pavlidis; Francis Creed
Journal:  Qual Life Res       Date:  2009-08-22       Impact factor: 4.147

5.  Poor Correlation Between Clinical Disease Activity and Mucosal Inflammation, and the Role of Psychological Comorbidity, in Inflammatory Bowel Disease.

Authors:  David J Gracie; Christopher J M Williams; Ruchit Sood; Saqib Mumtaz; M Hassan Bholah; P John Hamlin; Alexander C Ford
Journal:  Am J Gastroenterol       Date:  2016-03-22       Impact factor: 10.864

6.  Comorbid anxiety-like behavior in a rat model of colitis is mediated by an upregulation of corticolimbic fatty acid amide hydrolase.

Authors:  Haley A Vecchiarelli; Maria Morena; Catherine M Keenan; Vincent Chiang; Kaitlyn Tan; Min Qiao; Kira Leitl; Alessia Santori; Quentin J Pittman; Keith A Sharkey; Matthew N Hill
Journal:  Neuropsychopharmacology       Date:  2021-01-15       Impact factor: 7.853

7.  Health-related quality of life in patients with inflammatory bowel disease: a single-center experience.

Authors:  Maria Kalafateli; Christos Triantos; Georgios Theocharis; Dimitra Giannakopoulou; Efstratios Koutroumpakis; Aristidis Chronis; Apostolos Sapountzis; Vasileios Margaritis; Konstantinos Thomopoulos; Vasiliki Nikolopoulou
Journal:  Ann Gastroenterol       Date:  2013

8.  Effectiveness of behavioral-cognitive group therapy on depression, anxiety, and stress of patients with coronary heart disease.

Authors:  M Aghaei; E Samkhaniyan; A Mahdavi; J Faraji; Z Roshandel
Journal:  J Med Life       Date:  2015

9.  Sleep disturbance in Inflammatory Bowel Disease: prevalence and risk factors - A cross-sectional study.

Authors:  C Marinelli; E V Savarino; I Marsilio; G Lorenzon; T Gavaruzzi; R D'Incà; F Zingone
Journal:  Sci Rep       Date:  2020-01-16       Impact factor: 4.379

10.  Sarcopenia, severe anxiety and increased C-reactive protein are associated with severe fatigue in patients with inflammatory bowel diseases.

Authors:  Laura Tasson; Fabiana Zingone; Brigida Barberio; Romina Valentini; Pamela Ballotta; Alexander C Ford; Marco Scarpa; Imerio Angriman; Matteo Fassan; Edoardo Savarino
Journal:  Sci Rep       Date:  2021-07-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.